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Evolutionary conservation of the antimicrobial function of
mucus: a first defence against infection
Cassie R Bakshani1, Ana L Morales-Garcia1, Mike Althaus1, Matthew D Wilcox2, Jeffrey P Pearson2, John C Bythell1 and J Grant Burgess1
Mucus layers often provide a unique and multi-functional hydrogel interface between the epithelial cells of organisms and their
external environment. Mucus has exceptional properties including elasticity, changeable rheology and an ability to self-repair by re-
annealing, and is therefore an ideal medium for trapping and immobilising pathogens and serving as a barrier to microbial
infection. The ability to produce a functional surface mucosa was an important evolutionary step, which evolved first in the
Cnidaria, which includes corals, and the Ctenophora. This allowed the exclusion of non-commensal microbes and the subsequent
development of the mucus-lined digestive cavity seen in higher metazoans. The fundamental architecture of the constituent
glycoprotein mucins is also evolutionarily conserved. Although an understanding of the biochemical interactions between bacteria
and the mucus layer are important to the goal of developing new antimicrobial strategies, they remain relatively poorly understood.
This review summarises the physicochemical properties and evolutionary importance of mucus, which make it so successful in the
prevention of bacterial infection. In addition, the strategies developed by bacteria to counteract the mucus layer are also explored.
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INTRODUCTION
Bacterial infection in humans is becoming increasingly proble-
matic, particularly with the rise of multidrug resistance in
opportunistic pathogens, resulting in reduced effectiveness of
antibiotics.1 Consequently, there is an urgent need to develop
innovative approaches to tackle infection. An important strategy
adopted by many living organisms to combat tissue incursion by
microbes, is the secretion of a surface mucus layer.2 This
physicochemically exceptional interface appears to have first
evolved in the ctenophores3 and cnidarians.4 However despite its
clear importance and widespread presence in higher organisms,
the mechanisms of mucus production and its functionality are still
largely unknown, except in the case of the human MUC2 gene
product.5 A more comprehensive understanding of the chemical
and physical properties of mucus might suggest novel antimicro-
bial strategies for clinical application.
Mucus also constitutes an essential feature of the innate
immune system, considered to be universal within most phyla of
both aquatic and terrestrial metazoans,6 and plays a pivotal role in
the prevention of disease. The mucus layer functions as a
protective adherent secretion coating epithelial cells which line
bodily surfaces, primarily those that are routinely exposed to the
external environment and therefore microbes, including potential
pathogens.7 In humans, mucus coats the surface of the respiratory,
gastrointestinal and urogenital tracts,8 along with the middle ear9
and the ocular surface and tear film,10 which receive mucus from
the lacrimal glands.11 Aquatic invertebrates and fish also use a
mucus layer to protect the body, gill and gut surfaces.12 In
addition to serving as an antimicrobial barrier and a physically
protective layer, mucus has several physiological functions.
Importantly, mucus allows the exchange of oxygen, carbon
dioxide13 and nutrients and metabolites, whilst lubricating
surfaces, reducing damage due to shear,14 as well as reducing
dehydration of the epithelia and providing the polymeric matrix
which enables ciliary-mucus particle transport.
Although there are diverse functions of mucus, this review will
focus on the physical and chemical properties of mucus
responsible for its antibacterial activity and the evolutionary
conservation of these features throughout metazoan develop-
ment. Subsequent adaptations of microorganisms to overcome
the mucus barrier, to penetrate and degrade mucus will also be
discussed. The potential biomedical and biotechnological applica-
tions of mucus are also presented.
Evolution of the mucus layer
The synthesis and secretion of a functional surface mucus layer
first arose in the Cnidaria4 and Ctenophora.3 The Cnidaria are a
phylum of approximately 11,000 species15 of predominantly
marine invertebrates, which includes corals, anemones and
jellyfish. This phylum can be characterised as the first phylum to
have evolved radial symmetty, a medusoid or polyploid body form
and stinging cells called cnidocytes.16 The Ctenophora are a sister-
group to the Cnidaria and represent the most distant animal
relatives of humans.17 Analogous to the Cnidaria, they are
diploblastic and radially symmetrical18 and are known more
commonly as comb jellies. Despite the investigation of Cnidarians
as model systems used to study the evolution and developmental
biology in metazoans, the importance of the evolution of a
functional mucus layer in invertebrates is often neglected.
In corals, the luxury carbon hypothesis (LCH), proposed in the
1980s, that the primary function of mucus secretion was to
remove excess photosynthetic carbon19 produced by symbiotic
zooxanthellae. This excess results from low dietary nitrogen which
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restricts the allocation of carbon to growth.20 This theory suggests
that secretion of mucus, a carbon rich compound, fulfils this need.
However, it is unlikely that mucus, containing nitrogen rich
glycoproteins, would have evolved for this sole purpose.21 It
would be more appropriate, in this case, to excrete a high energy/
low nitrogen compound such as a lipid or simple sugar, which is
the case in aphids, for example.22 Furthermore, for tropical coral
species where nitrogen, essential for sustaining photosynthesis in
coral symbionts,23 is limiting,25 mucus production ameliorates the
N-limitation problem, as it represents a greater proportion of the
N-budget. In corals, the LCH is not applicable to other Cnidarians
that also possess a functional surface mucosa, but which do not
contain photosynthetic symbionts. Therefore, whilst mucus
secretion can provide a vehicle to excrete excess carbon in
symbiotic corals, this is unlikely to be the primary function of
mucus secretion.
It has since been suggested that mucus first evolved in corals
primarily for ciliary-mucus driven particle feeding and/or to
prevent smothering by sediments, thus simultaneously providing
physical protection as well as a means of accessing greater dietary
nitrogen via particle capture.24 For example, corals are known not
only to use mucus in trapping particles, but to then transport
trapped particulates, bacterial cells and detritus towards the
mouth and gastrovascular cavity via a process of cilia mediated
entrainment.25 Entrainment, in this case, describes the ability of
mucus to be dragged as a connected sheet or string across the
epithelial surface. The processes of particle entrapment, entrain-
ment and transport depend on the specific properties of mucus,
including its polymeric glycoprotein structure, which confers high
viscoelasticity and tensile strength. These properties ensure that
ciliary-mucus sheet transport is efficient, which is a universal
requirement in corals whether or not they possess symbionts. The
selective evolution of these properties also serves an additional
function—that of a physical barrier to bacteria.
Continuous mucus production and release is clearly important
and characteristic of many aquatic organisms, despite the high
associated energy costs. For example, the reef-building coral
Acropora acuminata is thought to dedicate up to 40% of its daily
net carbon fixation to this task alone.25
Although additional molecular evidence is needed, it can be
postulated that the development of the mucus layer represents a
major event in the evolutionary history of living organisms, one
that appears just as significant as the ‘text-book’ defining
characteristic of a blind gut (gastrovascular cavity) in the phylum
Cnidaria. Poriferans, commonly known as sponges, are basal
metazoans that precede the Cnidaria evolutionarily. There is some
evidence to suggest that Poriferans possess genes and genetic
structures which maybe evolutionary precursors of mucins,3,26,27
and in the cases of the barrel sponge Xestospongia testudinaria
and the silvery blue sponge Lamellodysidea herbacea are also able
to secrete some mucus.28,29 However, interestingly, evidence of a
functional surface mucosa in Poriferans is currently lacking.
Sponge tissues are continuously inundated with water and
environmental bacteria, with bacterial cells occurring throughout
these tissues and contributing 40–50% of their wet mass,30
although in some species this may be considerably lower. While
ctenophores and cnidarians, in particular corals, possess a
microbiota that is not only distinct from that of their immediate
environment, but also other coral species,24,31–33 the population
levels of bacteria within the tissues are much lower than in the
sponges and the ‘core microbiome’ of corals appears to be
relatively restricted.34 The evolution of effective barrier properties
in a functional surface mucosa therefore appears to be associated
with the general exclusion of bacteria from the bodily tissues,
except for a select core microbiome. Mucus generally serves to
keep eukaryotic cells and bacterial cells apart, therefore, in the
absence of a separating mucus layer, bacteria are found
throughout sponge tissues. With a mucus layer, as in the Cnidaria,
non-commensal bacteria are essentially excluded from cnidarian
tissues. It is plausible that, because sponges do not have a mucus
barrier layer their tissues are more inundated with bacterial cells,
and as a result, powerful antimicrobial secondary metabolites are
required to keep microbial growth in check. The lack of developed
tissue structures in the Porifera35 may be attributed to this inability
to exclude bacteria from bodily tissues, and the evolution of a
mucus barrier layer may have therefore been a critical evolu-
tionary step in the development of the Ctenophora and Cnidaria.
Detailed formal analysis of the evolution of mucin genes has
begun, allowing a phylogeny of the gel-forming mucin like genes
to be established.3
The exclusion of non-commensal bacteria may have initiated
the evolution of the alimentary canal and therefore the evolution
of higher organisms. The water-land transition and terrestrial life
also required adaptations to air breathing, resulting in the
evolution of respiratory surfaces (originating from the alimentary
canal) which faced the problem of providing sufficient gas
exchange on the one hand and being exposed to microorganisms
and particulate fouling on the other.
An airway epithelium lined with mucus evolved to serve as a
particle and pathogen trap, preventing microbes from penetrating
and infecting gas-exchanging regions in mammalian lungs. Mucus
and trapped particles are cleared from the lungs by cilia- mediated
mucus entrainment—essentially the same mechanism used for
feeding by corals, filter feeding ascidians and bivalves and ciliary
gliding by lower invertebrates.36 Histological studies on lungfish
(Neoceratodus forsteri and Protopterus aethiopicus), the oldest
living ancestors of tetrapod vertebrates, revealed the presence of
ciliated cells within the intestine.37 Furthermore, in P. aethiopicus,
ciliated cells and mucus secreting cells are present in the anterior
parts of the lungs,37 suggesting that during vertebrate evolution,
cilia-mediated mucus entrainment might have been lost in the
mammalian gut surface mucosa, whereas it developed into a
highly efficient particle clearance system in the airways.
The evolutionary history of mucin genes is somewhat con-
voluted and these structurally complex glycoproteins are thought
to be derived from the same ancestor as the von Willebrand
Factor (vWF),26 a glycoprotein involved in the mediation of
platelet adhesion within the blood.38 This is due to the occurrence
of the von Willebrand D domain in both mucins and vWF. Within
mucins, this domain is responsible for the polymerisation of mucin
monomers through production of intermolecular disulphide
bonds, subsequently allowing the gel forming mucin polymeric
structure.3 Despite these insights, the distribution of mucin genes
across all phyla is not well studied, with a concentration
predominantly on human mucin genes and their evolutionary
divergence from one another.3,39 One study that did focus on
early evolution found that mucus isolated from several species of
jellyfish, including Aurelia aurita, Chrysaora melanogaster and
Rhopilema esculenta possessed a qniumucin gene which showed
surprising structural similarity to MUC5AC40 (Fig.1), an important
mucin found in the human stomach and lungs.41 Similarly, mucins
isolated from the blue blubber jellyfish, Catostylus mosaicus had an
Fig. 1 Similarity in the amino acid sequence between qniumucin
from jellyfish and human MUC5AC. A similar tandem repeat of eight
residues is found in both mucins and the boxes highlight four of
these similarities. Although the human mucin is more flexible, both
proteins form a gel in water. Reprinted (adapted) with permission
from (Masuda et al. Mucin (qniumucin), a glycoprotein from jellyfish,
and determination of its main chain structure. J. Nat. Prod. 70,
1089–1092 (2007). Copyright (2007) American Chemical Society
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amino acid content high in Thr, Ala, Pro and Glu, which is
characteristic of bovine mucins.42 Therefore, whilst it has been
identified that secreted mucins likely evolved in early metazoans
and membrane-bound mucins evolved in the first vertebrates,26
suggesting there is some degree of divergence in their evolution,
the structural and functional similarities between the mucins of
early metazoans and higher mammals suggest they may be
functionally similar.40,42 This notion is reinforced by the similarities
seen in the structures of the mucus secreting cells of cnidarians
and humans (Fig. 2) and also in mucus composition, which is
comparable between taxonomically distinct phyla.43
Mucus composition
Mucus is predominantly composed of water, which equates to
approximately 95% of its overall wet mass, with the remaining 5%
composed of mucin glycoproteins (~3%) and other molecules
(~2%).44,45 The 2% constitutes both cellular debris and co-
secretions of soluble proteins such as secretory IgA, peptides,
lipids and nucleic acids,46 which fulfil specific roles.
The high water content requires the presence of regulatory
mechanisms which control the hydration of mucus lined air-
exposed surfaces such as the mammalian respiratory tract,
allowing both appropriate supply of water into mucus and air
into lungs. Secretion and absorption of water into and from the
mucus is facilitated by electrolyte secretion and absorption across
the underlining epithelial cells; a molecular machinery which
evolved as an adaptation to terrestrial life.47 The importance of the
hydration state of mucus and its link to transepithelial electrolyte
transport is evident in the human disease cystic fibrosis, where
genetic defects leading to either impaired abundance/activity of
the chloride/bicarbonate secreting ion channel CFTR (cystic
fibrosis transmembrane conductance regulator) or enhanced
activity of the sodium absorbing ion channel ENaC (epithelial
sodium channel)48,49 cause dehydration50 and high mucus
viscosity.51,52 This prevents cilia-mediated particle clearance which
eventually results in airway mucus plugging and lung infection.52
Mucin glycoproteins are the component of mucus that promote
its function as a lubricating gel,42 making mucus layers non-shear
resistant and shear compliant gels. While functionally conserved,
mucin glycoproteins are structurally complex43 and separated into
secreted soluble, secreted gel-forming and membrane-bound /
transmembrane mucins.5,45 Multiple transmembrane mucins have
now been identified.7,53,54 They are thought to be involved in
cellular signalling26 and on the airway surface, for example, they
are used to create a size exclusion barrier.55
Mucins can be characterised by the presence of a single mucin
domain, abundant in large repeat sequences rich in proline,
threonine and serine and commonly referred to as the PTS
domain.26,56 Mucins are among the largest known macromole-
cules, between 200 kDa and 200 MDa in size57 and they contain a
Fig. 2 Similarity between (a) mucus secretory cells of Cnidarians (b) human airway epithelium. Coral mucocytes and human goblet cells are
structurally similar and perform similar roles, which can be seen in the histological images of (c) a section from the coral Coelastrea aspera,
stained with toluidine blue,177 showing coral mucocytes surrounded by ectodermal cells (scale bar 10 µm) and (d) a section of human trachea,
H & E staining, showing human goblet cells surrounded by ciliated epithelial cells (scale bar 20 µm)
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large number of O-linked oligosaccharide side-chains.42,58 These
are composed of approximately 5–15 monomers that are added
post-translationally, however the process is not precisely repli-
cated, leading to variation in the size of the glycoprotein in nature.
The oligosaccharides attach to the protein core via O-glycosidic
bonds on hydroxyl side chains of both serine and threonine.45
There is also sparse glycosylation with branched oligosaccharides
N-linked to asparagine.59 In particular it is the oligosaccharide
chains42 and polymeric structure60 that are thought to confer the
highly viscoelastic properties of mucus, which confer its barrier
properties.
The oligosaccharide chains also play a crucial role in mucin
storage and secretion.61 Intracellular gel-forming mucins are
stored in a compact and condensed form in granules within
mucus-secreting cells. The condensed storage of mucins contain-
ing anionic oligosaccharide chains is possible due to a high
concentration of calcium ions and protons within the granules,
which both mask the negative oligosaccharide charges and
prevent electrostatic repulsion and thus expansion of the mucin
molecules.62,63 In addition, non-covalent interactions take place
between the D domains. Upon secretion of these granules, the
mucins expand 1000–3000 fold, taking up water to form a gel, as
calcium is exchanged for sodium and the pH rises.64 The presence
of bicarbonate significantly accelerates the uptake of calcium,
forming calcium carbonate and calcium bicarbonate,61 which is
present within the surface liquid. In addition to water, bicarbonate
is therefore an important determinant of mucus secretion,
hydration and transportability.61 In cystic fibrosis, for example,
functional absence of CFTR reduces the bicarbonate concentration
within the airway surface liquid, meaning secreted mucins are
more condensed and viscous.65 The integral roles of both water
and bicarbonate highlight the importance of the secretory
properties of mucosal surface epithelia.
Mechanisms of the mucus barrier function
Physical mechanisms. Within terrestrial organisms, the important
functions of mucus are to lubricate and hydrate the epithelium66
as well as to provide protection from bacterial infection. The
antibacterial properties of mucus are multifaceted, with some of
them occurring as a consequence of its other roles, it is difficult to
assign primary or secondary functions of the mucus layer, as they
are all intrinsically interlinked. Mucus prevents the passage of
bacteria due to its unique physicochemical characteristics. For
instance, its high viscosity prevents the penetration by pathogens,
whilst remaining permeable to water, gases and odorants.67 The
physicochemical properties of mucus and therefore its ability to
trap particles, may also be directly correlated to the associated
phospholipid and glycolipid content, as removal of these lipids
can reduce viscosity by up to 85%.68
In addition to their gel structure, mucus layers are continually
removed and regenerated,69 which detaches contaminants rapidly
and efficiently before they can reach the underlying surface
tissues.70 This cycle of exudation and degradation, known as
sloughing, determines the thickness of the mucus layer and plays
a significant role in the mucosal cleaning action.67 Mucus layer
thickness can vary with different tissues, organ structures and
under different physiological conditions.71 For example, within the
human gastrointestinal tract, the adherent mucus gel layer in the
stomach and colon is 50–200 µm deep,72 whilst in the eye the
mucus layer is 0.2–1.0 µm.73 Mucus layer thickness in the colon
can also be affected by microbial consortia composition, which is
influenced by variability in the host diet.74 In healthy women,
thickness and properties of cervicovaginal mucus can naturally
vary throughout the menstrual cycle75 due to fluctuating
hormones.76 Supplementary to these physical barriers, it is
important to recognise that there are also chemical components
to the defensive function of the mucus layer.
Physicochemical mechanisms. A key characteristic of mucin fibres,
which confer the exceptional particle-trapping ability of mucus, is
elasticity.67 Mucin fibres are flexible strings composed of
alternating heavily glycosylated and hence, hydrophilic regions,
with hydrophobic regions of bare protein.67 This conformation
allows them to trap particles using myriads of low-affinity bonds
that form and break easily and quickly. These intermolecular
forces are also present between neighbouring mucin fibres,
allowing them to re-arrange and re-anneal following shear
stress.67 Examples of these physiochemical mechanisms can be
seen in species of Cnidaria, as well as in higher organisms. For
example, mucus of the beadlet anemone Actinia equina contains
proteins that exhibit similar antibacterial activities to that of
lysozyme (1,4-β-N-acetylmuramidase).77 This enzyme plays a vital
antibacterial role by hydrolysing the peptidoglycan component of
bacterial cell walls, causing cells to lyse due to increased osmotic
pressure.78 This occurs following the breaking of glycosidic β1-4
bonds, which are present between N-acetylglucosamine (GlcNAc)
and N-acetylmuramic acid (MurNAc), found in the cell walls of
bacteria.79 The study found that the efficiency of the lysozyme-like
molecule in the anemone mucus was directly affected by
temperature, ionic strength and pH. The enzyme displayed
optimal antimicrobial effects in test conditions that are unlikely
to be experienced in the natural environment of A. equina,
particularly the elevated temperature of 37 °C. This may indicate
the limitations of this molecule in regards to its antibacterial
activity at lower temperatures and higher pH values.77
Hard and soft corals are both capable of producing antimicro-
bial molecules, however their mechanism of action may vary.80
Parerythropodium fulvum, a soft coral native to the Red Sea,
produces antimicrobial secondary metabolites with varying
polarities. This work also provided the first evidence of
antimicrobial activity in coral embryos against marine bacteria.81
Similarly, the Antarctic soft corals Gersemia antarctica and
Alcyonium paessable are able to secrete allelochemicals such as
homarine which have a bactericidal effect.82 These antimicrobial
compounds are secreted into the mucus layer and are an
important part of mucosal defence mechanisms. The efficacy of
the antimicrobial compounds in the absence of mucus, or indeed
the efficacy of the mucus in the absence of any additional
antimicrobial compounds is difficult to measure without their
chemical separation, which was not carried out in these studies.
When comparing the mucosal chemical defence of six
alcyonacean soft corals and six scleractinian hard corals against
Arthrobacter sp. and Vibrio sp., namely Vibrio metschnikovii, the
mucus of alcyonacean corals showed anti-microbial activity,
however the mucus of the scleractinian corals displayed little
inhibitory effect.80 Because of this, it was concluded that only the
soft coral species were able to produce anti-microbial compounds.
However, the method used to identify active metabolites only
identifies toxicity due to growth inhibition or cell death. Although
there was no recorded effect due to production of toxins, this
does not necessarily mean chemical defence mechanisms are
absent within scleractinian coral mucus. For example, it has been
shown that scleractinian corals have low constitutive expression of
antimicrobials, but produce them rapidly upon physical damage.83
Furthermore, it is likely that hard corals adopt chemical defence
mechanisms that are similar to those used by higher organisms,
whereby metabolites are produced that target specific bacterial
phenotypes.84 Such metabolites may affect motility, plasmid
transfer, production of antibiotics and could dampen quorum
sensing signals used by bacteria to mediate virulence.85
Metabolites employed for chemical defence within mucus have
also been shown to affect fungal pathogens such as Candida
albicans,86 which is associated with both superficial infection and
systemic, potentially fatal diseases. C. albicans cells were added to
media containing MUC5AC mucin and mucin-induced changes to
cell morphology were monitored. The presence of mucins
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prevented the formation of filamentous flocs containing hyphae,
which are necessary for permeation of epithelial surfaces.87
Instead, hyphal formation was largely suppressed and cells were
only able to form short pseudohyphae. Importantly, this assay was
repeated using two other mucins isolated from different sources,
MUC5B mucin from human saliva and Muc2 from porcine
intestinal mucus, which both showed the same effect.
Paneth cells, one of the principal, highly specialised epithelial
cell types present in the mammalian small intestine,88 are essential
for mucosal defence and maintenance of the gastrointestinal
barrier. They provide protection for neighbouring stem cells,
which differentiate into three other cell lineages, including mucus-
secreting goblet cells.89 In addition, Paneth cells secrete anti-
microbial proteins and peptides such as α-defensins into the
mucus,90 creating a gradient which extends from the cell surface
to the lumen.91 These defensins are thought to increase resistance
to infection by pathogens present in the intestinal lumen.92
Deficiency in Paneth cell α-defensins can therefore significantly
compromise mucosal immunity.93
Within the human colon, MUC2 mucin is responsible for the
formation of polymeric nets which contain zymogen granulae
protein 16.94 This protein is able to aggregate Gram-positive
bacteria such as Bacillus subtilis and Enterococcus faecalis by
binding to the peptidoglycan present in the cell wall, thus
inhibiting penetration of the epithelial cells.95 However, Gram-
negative strains investigated including Bacteroides fragilis and
Escherichia coli, remained unaffected. This process allows the
bacterial cells to be effectively immobilised at a safe distance from
Fig. 3 The properties of mucus, which allow resistance to microbial colonisation, can be divided into physical and chemical processes.
Physical processes include its gel properties, such as thickness, entrainment, sloughing and viscosity. Chemical processes include those
conferred by enzymes and secondary metabolites. The antibacterial metabolite shown here, Eunicellol A, is secreted into the mucus of the
Arctic soft coral Gersemia fruticosa
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the underlying epithelium, without necessarily requiring a
bactericidal effect.
The DMBT1 (deleted in malignant brain tumour 1) gene, which
is expressed predominantly by epithelia in the alimentary and
respiratory systems, is considered to play an important role in
regulating mucosal surface homeostasis and defence.96 The gene
encodes proteins that are involved in mucosal innate immunity,
along with gp-340 (DMBT1gp340), a mucin-like glycoprotein and
salivary agglutinin (DMBT1SAG).97 These molecules function by
binding to both Gram-positive and Gram-negative bacteria and
viruses.97 For example, DMBT1SAG also binds and agglutinates oral
streptococci, such as Streptococcus mutans.98 Mucus catalysed
aggregation of microbial cells, therefore appears to be an
important antimicrobial function.
The prevention of adherence is another method of chemical
defence42 and may be mediated by adhesin and receptor
analogues, which act as competitive inhibitors to the sites of
adhesion.99 They function most effectively in combination with
antibodies such as IgA, which is co-released in its secretory form
with mucus and works by blocking the sites of adhesion and
reducing motility of bacterial cells.100
An alternative anti-adhesive mechanism is the promotion of
motility,101 which causes increased rates of dispersal, resulting in
reduced rates of biofilm production. This was shown in
Pseudomonas aeruginosa, where exposure to MUC5AC rich mucin
significantly reduced the adhesion of P. aeruginosa to glass.102
However, the total immersion of the coverslips into the media
may present a potential flaw, as realistically the bacteria would be
acting at an air-liquid interface within the lungs,103 though there
are few ways this can be replicated experimentally without
specialist equipment.104 Conversely, mesogleal mucins from the
blue blubber jellyfish Catostylus mosaicus, have been shown to
reduce the adhesion of P. aeruginosa cells to human corneal
epithelial cells by 86%, due to oligosaccharide attached to mucins
preventing adherence by competing for binding sites upon the
mucins.42 The oligosaccharide chains of mucins secreted by airway
epithelia from cystic fibrosis patients display an abnormally high
level of sulphate esters51,105,106 and it is suggested that sulfation
might also change the binding of bacteria, although experimental
evidence for this is lacking.41 Minimal medium-based experiments
demonstrated that sulfated carbohydrates reduced the growth of
P. aeruginosa in comparison with their non-sulfated forms,107
suggesting that oligosaccharide sulfation protects mucin from
bacterial degradation. These results, however, need to be
confirmed in more physiological environments.
The varied physical and chemical mechanisms of mucus used to
resist colonisation and infection are presented in Fig. 3. However,
despite this array of strategies, bacteria have also evolved
sophisticated mechanisms to overcome them.
Bacterial colonisation of mucus
There are two mucus layers present within the human gastro-
intestinal tract,108 one of which is adherent to the epithelial cells,
whilst the other is a weaker gel which overlies this. The inner layer
remains relatively devoid of microbes, whilst the outer layer
contains a diverse community of commensal bacteria, necessary
to ensure good health.109 This healthy microflora is unlikely to
permeate the denser, adherent mucus, as this may stimulate an
immune response, compromising this niche for the enteric
microbiota.110 Constituent species of a healthy gut microflora,
appear to have to have fewer means to allow deeper mucosal
penetration, whilst pathogens are aided by increased motility and
additional factors promoting attachment.111
Cilia-mediated mucus clearance in the airways requires an
inverse composition of mucus layers. A recent 'gel-on-brush
model' suggests an almost liquid mesh (also known as periciliary
liquid) of membrane-spanning mucins (MUC1 and MUC4) and an
overlying denser gel-like layer consisting of MUC5AC/B which
serves as a particle trap.112 Based on the efficacy of airway muco-
ciliary particle clearance, lung mucosal surfaces in healthy
individuals were historically considered sterile, however, the
existence of a 'lung microbiome' is recently more accepted.113
Adhesion and motility
Adhesion is considered to be a critical stage in the development
of an infection, contributing to the virulence of a pathogen, and
where individual bacterial cells are prevented from adhering, they
are considerably less likely to successfully infect the host.114
Bacterial adhesion may be mediated by chemical components
within mucus which can act as chemoattractants.115 To test this,
one study investigated the chemotactic response of Vibrio
anguillarum to the skin and intestinal mucus of the rainbow trout,
Oncorhynchus mykiss, using a chemotaxis assay, where glass
capillaries containing different mucus substrates were submerged
into V. anguillarum cultures.116
Vibrio appears to be one of the bacterial genera most able to
colonise mucus in both mammals and other organisms and their
virulence has been tentatively linked to their motility.117 Vibrio
coralliilyticus for example, causes infection in two different species
of reef-building scleractinean coral, Pocillopora damicornis and
Acropora millepora.118 When these corals experience elevated
ambient temperatures, they become susceptible to heat stress,
which stimulates the release of the sulphur metabolite, dimethyl-
sulfoniopropionate (DMSP), in high concentrations within the
mucus.118 This elicits a chemotactic response from V. coralliiyticus,
a highly motile bacterium that uses DMSP to target corals
experiencing acute physiological stress, which are consequently
most vulnerable to infection. A chemotaxis assay established that
50% of the bacterial cells present, migrated into the 400 μm thick
mucus layer within 60 s of inoculation. However, one difficulty in a
number of coral mucus studies, is the method used to obtain the
mucus. A common method is coral milking, whereby coral
specimens are partially desiccated via emersion, encouraging
the production of large quantities of homogenous mucus.60 The
mucus collected in this way has lower viscosity and is
biochemically different to the mucus of the surface mucus layer.24
Therefore, it is likely that the anti-microbial properties of the
mucus were altered significantly. Despite this, it was also found
that V. coralliiyticus has no gene for degradation of DMSP, but the
detection of the molecule stimulated chemotaxis and chemokin-
esis simultaneously, allowing the bacterium to substantially
increase its velocity linearly with increasing DMSP concentrations,
suggesting that this molecule acts solely as a potent info-chemical
in this regard. DMSP itself has well-known antimicrobial properties
in other systems for example it prevents grazing by ciliatea in
plankton and is a widely abundant sulphur metabolite in marine
ecosystems.119 Therefore it is probable that V. coralliiyticus evolved
an ability to detect DMSP purely to identify heat-stressed corals,
indeed DMSP has been identified as a foraging cue for other
species of heterotrophic marine bacteria.120
Intriguingly, a similar sequence of events has been shown to
occur in the cystic fibrosis lung, whereby Pseudomonas aeruginosa,
a highly motile nosocomial pathogen, is able to target respiratory
epithelial cells.121 When the mucociliary clearance mechanisms
are impaired, an inflammatory response of the epithelial cells is to
produce CXC-chemokines, which act as chemoattractants for P.
aeruginosa.122 A recent in vitro study, using the human colorectal
adenocarcinoma cell line Caco-2, demonstrated that unidentified
low molecular weight proteins present in the supernatant of Caco-
2 cultures, also attracted P. aeruginosa in capillary chemotaxis
assays and increased bacterial motility and mucin penetration
(bovine submaxillary mucin).123 Thus, there is growing evidence to
suggest there is a link between production of chemoattractant
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molecules, motility of pathogens and their ability to colonise
mucosal layers.
Pathogens are also able to synthesise adhesin proteins that
recognise specific molecules in the mucus of the host.68 The strain
Vibrio AK-1 and its attachment to the mucus of Oculina
patagonica, a reef-building coral native to the Mediterranean,
was explored using a bleaching experiment and subsequent tests
using sepharose beads.124 It was found that coral fragments
incubated at 29 °C showed 50% bleaching, whilst fragments
incubated at 23 and 16 °C showed 17 and 0% bleaching,
respectively. Furthermore, β-D-galactopyranoside coated Sephar-
ose beads were then exposed to Vibrio AK-1 cells, and showed
98% cell adherence. These results suggested that Vibrio AK-1
identifies β-galactopyranosides on the coral surface using a
temperature-dependent adhesin protein, which is produced at
temperatures of 25 °C or above. Interestingly this correlates to the
temperature range within which O. patagonica is likely to begin
experiencing physiological stress due to elevated temperatures.125
Production of mucinases
Another factor contributing to the pathogenicity of a bacterium is
production of hydrolytic enzymes.111 Those that are able to
penetrate mucus have the ability to produce mucinase
enzymes126 (Fig. 4), which degrade mucin glycoproteins by
breaking down oligosaccharide chains.127 Helicobacter pylori, a
causal agent of gastric and duodenal ulcers in humans, has genes
coding for mucinase-like enzymes. However, whilst it is possible,
there is no solid evidence that H. pylori either produces or requires
a protease to penetrate mucus. Instead it uses multiple flagella
and its saw-tooth shape to bore through the mucus.128 In addition,
once at the mucosal surface it can solubilise mucus locally, by
using urease to generate a high pH which is mucolytic.129
When sputum from cystic fibrosis patients with a chronic
Pseudomonas aeruginosa infection is incubated for 6 h at 37 °C,
MUC5AC and MUC5B content decreases by more than 85% during
incubation, an effect which was sensitive to serine protease
inhibitors.130 There are multiple sources of proteases in cystic
fibrosis airway surface liquid, including neutrophils,131 however, P.
aeruginosa also releases the serine protease IV.132 Furthermore,
the P. aeruginosa metalloprotease elastase B (pseudolysin)
degraded both MUC5AC and MUC5B.130 A recent genome-wide
expression screen using RNA-Seq analyses of the P. aeruginosa
laboratory strain PAO1, identified genes such as PA3247 which
code for putative proteases and are associated with the ability to
breakdown mucin.133 As mentioned above, sulfated mucin
oligosaccharides protect mucin molecules from bacterial degrada-
tion; however, bacteria including P. aeruginosa have evolved the
ability to secrete mucin sulfatases, thus bypassing the protective
chemical oligosaccharide-chain modification and enabling further
proteolytic digestion of mucins.134
Escherichia coli which can cause intestinal disease, urinary tract
infections and sepsis in humans,135 is able to cross both the outer
and inner mucosal layers of the human gut epithelium via the
expression of proteases136 such as SslE, a zinc-metalloprotease
enzyme135 which degrades both MUC2 and MUC3 mucins
expressed in adenocarcinoma cell lines.137,138 However, they are
less glycosylated due to lower activity of glycosyltransferases139
and this would make them more susceptible to proteolysis than
native mucins. Similarly, Vibrio cholerae, possesses a HapA gene
encoding a soluble hemagglutinin/protease enzyme.140 There is
some evidence to suggest that V. cholerae is dependent on this
mucinase for its virulence, as mutants deficient in HapA are unable
to degrade ovomucin from chicken eggs.141
The intestine of a healthy human is colonised by up to 1014
bacteria, belonging to about 500 different species.142 Whilst
Fig. 4 Mucinases are important hydrolytic enzymes that can contribute to the penetration of mucus, an important mechanism of bacterial
pathogenesis. E. coli degrades mucins using a zinc metalloprotease and members of the genus Vibrio produce a hemagglutinin protease.
Using these mucolytic enzymes, pathogens can cross human and coral protective mucus layers. Image adapted from.135
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pathogenic bacteria are known to produce mucolytic enzymes,
there are also species within the healthy gut microflora that are
able to metabolise mucin-derived compounds.143 Due to high
rates of mucus synthesis and secretion in the human gut, there is a
continual influx of nutrients, which provides a novel ecological
niche and direct source of nutrition for enteric microbes that are
able to degrade mucus and its derivatives.144 This typically occurs
when there is an insufficient supply of dietary fibre145 such as in
the colon where carbon sources are more limited.146
Akkermansia muciniphila is a resident bacterium of the human
gastrointestinal tract,146 present in approximately 75% of the
population147 and constitutes 3–5% of the bacterial content in
healthy individuals.148 It is adapted to degrade host mucus as a
nutrient and this may provide its only carbon and nitrogen
source.149 A. muciniphila produces 61 proteins (2.8% of total
proteins produced) that are implicated in the degradation of
mucin, including sulfatases, proteases, glycosyl hydrolases and
sialidases.147 When grown on mucin enriched media, 30 hydro-
lases involved in the degradation of mucin were significantly
upregulated compared to growth on glucose enriched media.150
However, despite living in and deriving nutrition from the mucosal
environment, A. muciniphila does not adhere to the mucus.151 Its
presence in the gastrointestinal tract of humans and animals may
instead fortify mucosal defence by adhering to the intestinal
epithelia and subsequently strengthening the enterocyte
monolayer.151
Similarities between the mucus layer and bacterial biofilm EPS
Bacteria, in a manner akin to higher organisms and their mucus,
also possess a hydrated polymeric layer that encases their
multicellular assemblies. Biofilms are the primary form of life of
bacteria, in which individual cells form a dynamic and self-
regulated network, whilst attached to a surface. Attachment to a
surface in the form of a biofilm can often confer protection against
exogenous threats and allow nutrient accumulation.152 Biofilms
are highly tolerant to stress,153 as the surrounding matrix limits the
mass transfer of antimicrobial agents and because biofilm cells
express different genes to those of their planktonic counter-
parts,154 they have altered metabolic processes. Natural biofilms
are formed by a mixture of interacting species that occupy
dynamic microenvironments. Biofilms are supported by a plethora
of intertwined extra-cellular polymeric substances (i.e., the EPS
matrix), which is mainly composed of polysaccharides, proteins
(including glycoproteins) and eDNA. The synergy between these
components is key to the success of bacterial biofilms.155 The
biofilm matrix resembles a mucus layer in many respects. It is a
highly hydrated layer that provides a scaffold in which the
microorganisms are embedded. The EPS matrix protects against
environmental attacks, neutralising exposure against antimicrobial
agents, such as biocides and antibiotics as well as xenophobic
pollutants such as heavy metals and hydrocarbons. In some cases,
the EPS matrix can also provide cryo and osmoprotection.156 Part
of the protection that the EPS layer can provide stems in its ability
to anchor bacteria to surfaces; this is achieved through adhesive
polymers that contribute to surface adhesion as well as bacterial
co-adhesion and aggregation.157 The hydrated matrix is a
viscoelastic fluid and as such it can withstand external forces
applied in a compressive, tensile or shear mode. Bacterial biofilms
thus may flow along surfaces and yet remain attached. These
mechanical strategies that allow them to attach, flow and relocate
to more favourable niches are key to their persistence and in their
ability to cause infection. The structure and composition of the
biofilm directs the perfusion of nutrients. Concentration gradients
of oxygen, nitrite, nitrate, ammonia and methane as well as pH
also exist throughout the biofilm, to form distinct chemical
microenvironments at different depths.158 Thus, compositional
and structural properties, dependent on the matrix viscoelastic
properties, are vital in the life cycle of a biofilm.159
It should be noted that the matrix and bacterial cell surfaces can
also incorporate glycoproteins.160 Bacterial glycoproteins largely
fall into asparagine linked (N-linked) and serine-threonine-linked
(O-linked). Although mucus is also known to have the latter type
of linkage, the structure of their glycoproteins varies markedly,
making a direct comparison of functions difficult. In Eukaryotes
glycoproteins contain N-acetylglucosamine, fucose or N-acetylga-
lactosamine, whereas in bacteria they contain atypical mono-
saccharides such as 2,4-diacetamido-2,4,6-trideoxyhexose, N-
acetylfucosamine, pseudoaminic acid and legionaminic acid.
Whilst glycoproteins in mucus fulfil a crucial structural role, they
serve more specialised functions in bacteria: in some organisms
they form crystalline S-layers, which protect bacteria against
external attacks and permeate macromolecules. Glycosylated
proteins are involved in bacterial pathogenicity and are compo-
nents of motile and adhesive pili and flagella as well as a variety of
adhesins, enabling virulence and colonisation of the host.161 Given
the complexity of the inter-relationships between mucus and
microbes, a deeper understanding of these mechanisms could
lead to the development of more effective antimicrobial
processes.
Biotechnological implications
Mucins show great potential as molecules which can assist in anti-
infective therapies and in recent years significant advances have
been made. For example, in inflammatory bowel disease (IBD),
including Crohn’s disease and ulcerative colitis, mucus layer
thickness is reduced along.162 As a potential non-invasive
treatment, it has been proposed that mucin-derived CYS domain
molecules, rich in cysteine, could be administered to the
gastrointestinal tract of individuals suffering with IBD.163 CYS
domains, depending on their number and the proximity between
adjacent domains, may confer the tight/loose net properties of
mucus.163 Delivery of a molecule containing CYS domains to the
mouse gut was able to fortify the mucus barrier, increasing its
thickness and making it less penetrable to inert, fluorescently-
labelled particles.163 In addition, several further changes were
observed, notably, an increase in numbers of probiotic lactoba-
cilli.164 This molecule also shows potential as a contraceptive, as
when delivered to the cervical mucus, the polyCYS molecule
favours the formation of cross-links between mucins, resulting in a
change in the mucus mesh size and making it less permeable to
sperm cells.164 Further work is required to assess the efficacy of
these molecules in reinforcing the mucus layer, to prevent
infection, however this is a promising advance in the application
of mucus and its constituent mucins to biomedicine.
Mucin glycoproteins in cancer show modifications, both in
mucin expression and their O-glycosylation profile.165 For
example, epithelial cancer cells and early epithelial premalignant
lesions are known to express immature truncated glycans.166
Cancer biomarker assays usually centre around detection of
changes in expression and bio-distribution of products derived
from cancer cells.165 Therefore, new assays are being developed to
detect specific cancer-associated glycoforms of mucins.165
Jellyfish mucins have been described as potential candidates for
manufacturing protective coatings, as they are non-toxic and can
be harvested from all parts of the jellyfish.42 In addition, it has
been speculated that mucins could be used in future to coat
implants.86 More specifically, Muc5b mucin has been proposed as
a useful indicator to track the occurrence and monitor treatment
efficacy in ocular diseases such as dry eye syndrome.167 Mucus is
also being explored as a composite material in hydrogels to cover
wounds and prevent nosocomial infection following surgery.168
However, as mucins form gels under low ionic strength and low
pH, they are not compatible with the external wound
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environment, thus mucin hydrogels require reconstitution with
other macromolecules such as methylcellulose, which act as an
adjuvant to form a hybrid biopolymer. There are some limitations
to the biotechnological use of mucus, which include the difficulty
in harvesting this substance in large quantities without exploiting
and detrimentally impacting natural populations.169 Additionally,
acquisition of mucins from the crude mucus on a commercial
scale may require volatile toxic chemicals, which could compro-
mise their use in biomedicine.42 Despite this, Qniumucin has been
investigated for its potential in the treatment of osteoarthritis170
and has since entered clinical trials to establish its suitability for
use in regeneration of artificial cartilage.171 In addition, bioactive
compounds are beginning to be isolated from catfish mucus,
which could be used in wound healing, as they have an inhibitory
effect on growth of clinically relevant pathogens including
Pseudomonas aeruginosa, Staphylococcus aureus and Escherichia
coli, which is similar to that of gentamicin.172 Progress in this area
however, will rely on the development of methods that allow large
yields of mucus to be obtained, and this is not yet possible.
Experimental techniques used in the collection and study of
mucus
Investigating the in situ biophysical and functional properties of
mucus has been experimentally challenging due to the limited
number of suitable methods that can be used to obtain and purify
mucins. This is partly due to their complexity, large size and
heterogeneity.173 Whilst they are available commercially, the
industrial method of preparation usually requires treatment with
proteases, which causes the mucin fibres to become un-cross-
linked and degraded174 rendering them incapable of forming their
original physiologically relevant hydrogel structure.5,41,102,175
Therefore, whilst it is still possible to study the composition and
constituents of mucus, to fully understand its barrier properties it
is essential that it is able to reanneal under experimental
conditions.
Methods to remove bacteria within mucus samples such as
autoclaving and filtration present additional difficulties. Autoclav-
ing denatures proteins due to the prolonged period of intense
heat and pressure, whilst filter sterilisation is entirely ineffectual
due to mucus viscosity. This makes working on the microbiological
components of natural mucus particularly challenging. Whilst
studies are available that described the process used to obtain
and remove debris from porcine stomach and small intestinal
mucus,176 there is a paucity of detailed protocols which document
reliable methods of subsequent mucin purification from crude
mucus exudate in the literature. The most appropriate methods
involve homogenisation, centrifugation, freeze-drying and recom-
bination of the individual components. This process is time
consuming, taking approximately one week to purify 1 g of gastric
mucins and 2 weeks to purify 1 g of intestinal mucins.
CONCLUSIONS
There is increasing evidence to indicate that mucin genes are
functionally conserved throughout metazoan evolution from early
evolving metazoans, such as cnidarians and ctenophores, to
higher organisms, including terrestrial mammals and humans.40,42
Nevertheless, whilst some work is being done to reveal the
evolutionary basis of these complex glycoproteins,3,26 the
importance of the early evolution of mucus has not previously
been recognised. The study of the properties of the mucus layer is
a critically important area that can provide insights into their
molecular structure, and the precise mechanisms by which
infection can be thwarted.
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